January 25, 2018 01:54 PM EST
China

Fast-grow­ing Shang­hai Phar­ma to plant foot in San Diego, hunt­ing deals in US and Eu­rope

Amber Tong

A mul­ti-bil­lion dol­lar Chi­nese phar­ma con­glom­er­ate, blessed with mu­nic­i­pal gov­ern­ment back­ing, is spread­ing its wings to the US and Eu­rope with eyes on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump blog: Top HHS spokesper­son re­signs with­in weeks of be­ing sworn in

ICER finds GSK in­halers of­fer ad­van­tages over gener­ic com­peti­tors

Pli­ant calls it quits on Phase 2b id­io­path­ic pul­monary fi­bro­sis study

Bio­haven’s ion chan­nel drug fails piv­otal bipo­lar ma­nia study

No­vo Nordisk signs $354M part­ner­ship with AI-guid­ed biotech for ‘risky’ new meta­bol­ic mech­a­nisms

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times